| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2007;83:921-929
© 2007 The Society of Thoracic Surgeons
a University at Albany, State University of New York, New York, New York
b St. Peter’s Hospital, Albany, New York, New York
c Mercy Hospital, Buffalo, New York, New York
d New York University Medical Center, New York, New York
e Medical University of Ohio, Toledo, Ohio
f Rush University Medical Center, Chicago, Illinois
g Columbia-Presbyterian Medical Center, New York, New York
h Duke University Medical Center, Durham, North Carolina
Accepted for publication September 15, 2006.
* Address correspondence to Dr Hannan, State University of New York at Albany, Department of Health Policy, Management, and Behavior, One University Place, Rensselaer, NY 12144 (Email: elh03{at}health.state.ny.us).
Background: Numerous studies have developed a "severity score" or "risk index" for short-term mortality associated with coronary artery bypass graft (CABG) surgery, but very few studies have developed risk indices derived from statistical models to predict outcomes for cardiac valve replacement patients.
Methods: Data from New York’s Cardiac Surgery Reporting System in 2001 to 2003 were used to develop statistical models that predict mortality for valve surgery and for valve/CABG surgery. These models were used to develop risk indices based on the type of valve surgery performed and several patient risk factors. The fit of each index was tested by examining the correspondence of expected and observed mortality rates for various risk score ranges using New York data between 1998 and 2000.
Results: There were a total of 11 risk factors for valve patients without CABG surgery and 12 risk factors for patients with both valve and CABG surgery. Risk factors represented measures of demographics, type of valve surgery, previous open heart surgery, ventricular function, hemodynamic state, and various comorbidities. Possible variable scores ranged from 0 to 7 in the isolated valve model and 0 to 5 in the valve/CABG model. The highest overall risk scores possible for the two models were 49 for isolated valve surgery and 35 for valve/CABG surgery, and the highest scores observed for any patient were 32 and 26, respectively.
Conclusions: These valve surgery risk indices will enable providers to estimate patients’ short-term mortality risk and allow for comparisons of valve surgery outcomes with other regions.
Related Article
Ann. Thorac. Surg. 2007 83: 930.
This article has been cited by other articles:
|
|
 |
|
  R. H. Jones The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1707 - 1718. [Full Text] [PDF]
|
|
|
|
 |
|
 M. van Gameren, A. P. Kappetein, E. W. Steyerberg, A. C. Venema, E. A.J. Berenschot, E. L. Hannan, A. J.J.C. Bogers, and J. J.M. Takkenberg Do We Need Separate Risk Stratification Models for Hospital Mortality After Heart Valve Surgery? Ann. Thorac. Surg., March 1, 2008; 85(3): 921 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Rahimtoola The Year in Valvular Heart Disease. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 760 - 770. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Marcheix, Y. Lamarche, C. Berry, A. Asgar, J.-C. Laborde, A. Basmadjian, A. Ducharme, A. Denault, R. Bonan, and R. Cartier Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1150 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Edwards Invited commentary Ann. Thorac. Surg., March 1, 2007; 83(3): 930 - 930. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
